Rheinmetall's Field Hospital Windfall Fails to Silence Questions About the Growth Trajectory

Rheinmetall's €500M rescue station order boosts backlog, but ATACMS delays and F126 cuts trim outlook; cash flow turns deeply negative.

The Bundeswehr's latest order for Rheinmetall — 149 additional mobile rescue stations worth more than €500 million gross — arrived with the kind of timing that should, in theory, have given the Düsseldorf-based defense group a clean news cycle. The contract, drawn from a framework agreement signed in late 2024 and booked as far back as July, pushes the total order to 165 systems with a combined value exceeding €600 million. It stands as the largest single award ever received by the Rheinmetall Project Solutions GmbH subsidiary, with production slated to begin in the first quarter of 2027.

The market's response was polite rather than enthusiastic. Shares edged up 1.0 percent to close at €1,217.00 on Monday, a modest gain that reflects a broader reality: the company's order book is swelling, yet the investment community remains split on what lies ahead.

That ambivalence has deep roots. Just days earlier, Rheinmetall conceded to Reuters that its planned ATACMS missile production venture with Lockheed Martin is running behind schedule — a delay that adds to a growing list of speed bumps. The company pegged its own share of that program at €12.4 billion, with the total project volume, including partner KNDS, reaching roughly €25 billion.

The ATACMS slippage follows an earlier setback that carried a more immediate financial sting. Earlier this month, Rheinmetall trimmed its full-year revenue guidance to a range of €13.7 billion to €14.2 billion after the German government scrapped its planned procurement of F126 frigates. Reuters calculated the resulting cut at €300 million, though the company reaffirmed its operating margin guidance of around 19 percent.

The Numbers Tell Two Stories

The first-half figures offer plenty of ammunition for the bulls. Group revenue climbed 39 percent to €5.227 billion, while operating profit surged 74 percent to €786 million. The order backlog reached €80.5 billion as of June 30, with €16.2 billion in new nominations added during the half.

Yet the cash flow statement tells a more sobering tale. The second quarter produced operating cash flow of minus €1.331 billion, dragging the first-half total to minus €1.616 billion. For a defense contractor with long production cycles and heavy upfront investment, such outflows are hardly unusual — but they warrant closer scrutiny when paired with a lowered revenue forecast.

Analysts have responded with a mix of adjustment and caution. Jefferies, reacting to the half-year numbers on August 14, lifted its price target from €1,300 to €1,350 while maintaining a Buy rating, citing model revisions tied to second-quarter results.

JPMorgan's David Perry struck a different tone. He kept a Neutral stance with a €1,350 target, arguing that other European defense names offer better value. His reservations center on the medium term: the bank projects lower revenues for 2027 through 2030, with earnings estimates running as much as 17 percent below the market consensus.

A Portfolio Beyond Weapons

The rescue station order does highlight the breadth of Rheinmetall's offering beyond traditional weapons systems. Each mobile unit consists of two self-contained containers that can be assembled and disassembled by a team of four soldiers, with a significant portion of the order featuring ballistic protection for operations closer to the front lines.

But the contract does little to resolve the fundamental debate about growth momentum beyond 2026 — the question of whether the current pace of Bundeswehr orders can hold if defense budgets evolve differently than currently projected.

The chart offers its own commentary. The stock is trading back near its 100-day moving average of €1,217.90, essentially at Monday's closing level, while remaining well below the 200-day average of €1,440.55 — technical confirmation, if any were needed, of the medium-term skepticism JPMorgan articulated.

At Monday's close, the shares sat roughly 11 percent above their 50-day average, evidence of a recovery that has been building over recent weeks. Still, the stock remains about 39 percent below its all-time high of €2,007.00 reached in early October of last year, and it is down 22 percent since the start of 2025 — a reminder that cancelled orders and delayed production schedules carry weight with investors, even when the operational fundamentals remain structurally sound.

The broader sector has been mixed of late, with the DAX touching a record high last week before easing slightly at the start of this one. For Rheinmetall, the immediate picture is one of operational strength and order momentum, shadowed by questions about timing, cash, and the durability of the defense spending cycle.